Skip to main content

Advertisement

Table 5 Multivariate analysis for OS and PFS.

From: Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

Overall Survival (OS) P value
Tumour control (SD, CR, PR) 0.007
Brain progression (PD)  
KPS <70 0.024
KPS ≥ 70  
Age ≤ 65 years 0.792
Age > 65 years  
RPA 1 0.004
RPA 2  
RPA 3  
Progression Free Survival (PFS) P value
Tumor control (SD, CR, PR) 0.001
Brain progression (PD)  
KPS <70 0.05
KPS ≥ 70  
No extracranial disease 0.810
Extracranial disease  
Age > 65 years 0.310
Age ≤ 65 years  
RPA 1 0.001
RPA 2  
RPA 3